Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (41-50 of 297) with videos related to

Pageof 30
Sort By:
Therapeutic Advances in Psychopharmacology|May 26, 2021
Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depressionReiji Yoshimura, Naomichi Okamoto, Yuki Konishi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini reviewReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Therapeutic Advances in Psychopharmacology|December 20, 2021
Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary studyNaomichi Okamoto, Takashi Hoshikawa, Atsuko Ikenouchi, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatmentReiji Yoshimura, Koshiro Tsuji, Nobuhisa Ueda, et al.
International Clinical Psychopharmacology|November 20, 2019
Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophreniaHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case reportHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Cureus|July 22, 2021
Vortioxetine Improved Depressive State In Parkinson's DiseaseReiji Yoshimura, Atsuko Ikenouchi, Naomichi Okamoto, et al.
Human Psychopharmacology|October 31, 2002
Changes in plasma monoamine metabolites during acute lithium intoxicationReiji Yoshimura, Yasuhisa Yamada, Nobuhisa Ueda, et al.
Psychiatry and Clinical Neurosciences|October 1, 2009
Trichotilliomania responding to low-dose fluvoxamineAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, et al.
Brain Research. Molecular Brain Research|July 14, 2004
Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medullaReiji Yoshimura, Lu Xu, Baoyong Sun, et al.
Pageof 30

Showing results (41-50 of 297) with videos related to

Sort By:
Pageof 30
Therapeutic Advances in Psychopharmacology|May 26, 2021
Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depressionReiji Yoshimura, Naomichi Okamoto, Yuki Konishi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini reviewReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Therapeutic Advances in Psychopharmacology|December 20, 2021
Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary studyNaomichi Okamoto, Takashi Hoshikawa, Atsuko Ikenouchi, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatmentReiji Yoshimura, Koshiro Tsuji, Nobuhisa Ueda, et al.
International Clinical Psychopharmacology|November 20, 2019
Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophreniaHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case reportHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Cureus|July 22, 2021
Vortioxetine Improved Depressive State In Parkinson's DiseaseReiji Yoshimura, Atsuko Ikenouchi, Naomichi Okamoto, et al.
Human Psychopharmacology|October 31, 2002
Changes in plasma monoamine metabolites during acute lithium intoxicationReiji Yoshimura, Yasuhisa Yamada, Nobuhisa Ueda, et al.
Psychiatry and Clinical Neurosciences|October 1, 2009
Trichotilliomania responding to low-dose fluvoxamineAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, et al.
Brain Research. Molecular Brain Research|July 14, 2004
Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medullaReiji Yoshimura, Lu Xu, Baoyong Sun, et al.
Pageof 30